These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21261727)

  • 21. Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease.
    Masterton GS; Plevris JN; Hayes PC
    Aliment Pharmacol Ther; 2010 Apr; 31(7):679-92. PubMed ID: 20415840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
    Yu J; Chu ES; Hui AY; Cheung KF; Chan HL; Leung WK; Farrell GC; Sung JJ
    Biochem Biophys Res Commun; 2007 Apr; 356(1):53-9. PubMed ID: 17350593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.
    Alwayn IP; Andersson C; Zauscher B; Gura K; Nosé V; Puder M
    Transplantation; 2005 Mar; 79(5):606-8. PubMed ID: 15753852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased susceptibility to experimental steatohepatitis induced by methionine-choline deficiency in HBs-Tg mice.
    Fu MM; Sun R; Tian ZG; Wei HM
    Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):513-9. PubMed ID: 20943461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men.
    Tartibian B; Maleki BH; Abbasi A
    Clin J Sport Med; 2011 Mar; 21(2):131-7. PubMed ID: 21358504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
    Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A
    Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.
    Romestaing C; Piquet MA; Letexier D; Rey B; Mourier A; Servais S; Belouze M; Rouleau V; Dautresme M; Ollivier I; Favier R; Rigoulet M; Duchamp C; Sibille B
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E110-9. PubMed ID: 17986629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats.
    Gudbrandsen OA; Wergedahl H; Berge RK
    Nutrition; 2009 May; 25(5):574-80. PubMed ID: 19101115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the fatty acid composition of the liver with the administration of N-3 polyunsaturated fatty acids and the effects on warm ischemia/reperfusion injury in the rat liver.
    Iwasaki W; Kume M; Kudo K; Uchinami H; Kikuchi I; Nakagawa Y; Yoshioka M; Yamamoto Y
    Shock; 2010 Mar; 33(3):306-14. PubMed ID: 19543146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.
    Kobyliak N; Falalyeyeva T; Bodnar P; Beregova T
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):123-130. PubMed ID: 27660157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive quantification of triglyceride content in steatotic rat livers by (1)H-MRS: when water meets (too much) fat.
    Heger M; Marsman HA; Bezemer R; Cloos MA; van Golen RF; van Gulik TM
    Acad Radiol; 2011 Dec; 18(12):1582-92. PubMed ID: 22055799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
    Giudetti AM; Beynen AC; Lemmens AG; Gnoni GV; Geelen MJ
    Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.